Free Trial

OmniAb (OABI) Stock Price, News & Analysis

OmniAb logo
$1.74 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.76 +0.02 (+1.38%)
As of 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About OmniAb Stock (NASDAQ:OABI)

Key Stats

Today's Range
$1.69
$1.78
50-Day Range
$1.25
$1.86
52-Week Range
$1.22
$4.96
Volume
389,225 shs
Average Volume
651,890 shs
Market Capitalization
$212.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

OmniAb Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

OABI MarketRank™: 

OmniAb scored higher than 62% of companies evaluated by MarketBeat, and ranked 410th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OmniAb has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    OmniAb has only been the subject of 1 research reports in the past 90 days.

  • Read more about OmniAb's stock forecast and price target.
  • Earnings Growth

    Earnings for OmniAb are expected to grow in the coming year, from ($0.61) to ($0.46) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OmniAb is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OmniAb is -3.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    OmniAb has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about OmniAb's valuation and earnings.
  • Percentage of Shares Shorted

    8.23% of the float of OmniAb has been sold short.
  • Short Interest Ratio / Days to Cover

    OmniAb has a short interest ratio ("days to cover") of 8.
  • Change versus previous month

    Short interest in OmniAb has recently increased by 1.65%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    OmniAb does not currently pay a dividend.

  • Dividend Growth

    OmniAb does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.23% of the float of OmniAb has been sold short.
  • Short Interest Ratio / Days to Cover

    OmniAb has a short interest ratio ("days to cover") of 8.
  • Change versus previous month

    Short interest in OmniAb has recently increased by 1.65%, indicating that investor sentiment is decreasing.
  • News Sentiment

    OmniAb has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for OmniAb this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, OmniAb insiders have bought 59.58% more of their company's stock than they have sold. Specifically, they have bought $130,100.00 in company stock and sold $81,528.00 in company stock.

  • Percentage Held by Insiders

    Only 8.60% of the stock of OmniAb is held by insiders.

  • Percentage Held by Institutions

    72.08% of the stock of OmniAb is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OmniAb's insider trading history.
Receive OABI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OmniAb and its competitors with MarketBeat's FREE daily newsletter.

OABI Stock News Headlines

Chairman of OmniAb Picks Up 3.0% More Stock
Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript
See More Headlines

OABI Stock Analysis - Frequently Asked Questions

OmniAb's stock was trading at $3.54 at the beginning of the year. Since then, OABI stock has decreased by 50.8% and is now trading at $1.74.
View the best growth stocks for 2025 here
.

OmniAb, Inc. (NASDAQ:OABI) posted its earnings results on Thursday, May, 8th. The company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). The company earned $4.15 million during the quarter, compared to analyst estimates of $4.49 million. OmniAb had a negative trailing twelve-month return on equity of 21.37% and a negative net margin of 229.11%.
Read the conference call transcript
.

Shares of OABI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OmniAb investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Arista Networks (ANET), Advanced Micro Devices (AMD), CrowdStrike (CRWD) and Adobe (ADBE).

Company Calendar

Last Earnings
5/08/2025
Today
7/01/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Business Services
Current Symbol
NASDAQ:OABI
Fax
N/A
Employees
7
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$11.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+308.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$62.03 million
Net Margins
-229.11%
Pretax Margin
-254.78%

Debt

Sales & Book Value

Annual Sales
$26.39 million
Price / Cash Flow
N/A
Book Value
$2.37 per share
Price / Book
0.72

Miscellaneous

Free Float
111,631,000
Market Cap
$209.47 million
Optionable
Optionable
Beta
-0.02
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:OABI) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners